Kobilka Institute of Innovative Drug Discovery, the Chinese University of Hong Kong, Shenzhen
Kobilka Institute of Innovative Drug Discovery and Arieh Warshel Institute of Computational Biology are the first batch of Nobel laureate labs at the University. These two institutes are significant milestones in the University’s attempt to evolve into a world research university.
Professor Kobilka wishes that young and talented scientists could work on receptor structural biology, physiology and pharmacology in collaboration with top pharmaceutical companies to commercialize innovative drugs.
The Institute will help to attract excellent researchers and open up new opportunities for Longgang and Shenzhen with respect to life science industry.